OncoSpark and ELLKAY Announce New Partnership to Use Interoperability to Solve Prior Authorization Issues in Oncology
JACKSONVILLE, Florida, October 6, 2021 / PRNewswire / – OncoSpark, Inc., a leader in data-driven value-driven care technology services, and ELLKAY, LLC, a leader in healthcare interoperability for over 19 years, have joined forces forces to solve the challenge of prior authorization in the oncology space. OncoSpark’s platform, AuthParency, is the only solution dedicated to this. The platform was built with a personalized approach to interoperability through ELLKAY.
OncoSpark and Ellkay are disrupting the healthcare space by solving pre-authorization barriers.
The OncoSpark team worked in tandem with ELLKAY’s interoperability architects to ensure the solution addressed the challenges presented by oncology: clinical variables, pathways, exceptions, and health policy considerations. The collaboration resulted in a solution that ensures pre-clearance in oncology practices through seamless connectivity providing the data providers and staff need to focus on the patient and gives patients confidence and clarity as to how they are doing. are covered for their care as well as to alleviate delays this current process creates.
Jordan johnson, Chief Innovation Officer of OncoSpark said, âPrior authorization remains the biggest issue for cancer patients, and current oncology practices use many systems with disparate data that is neither relational nor valuable when unstructured / siled. Together with ELLKAY and AuthParency, we have created the subject matter expertise of the process by integrating over 200 discrete data points that link the practice to the payer to the pharmaceutical industry. “
Prior authorization has long created unnecessary financial burdens and challenges for hospitals, providers and patients. The AuthParency platform mitigates financial toxicity and delays by promoting unparalleled transparency for patients, payers, pharmaceutical companies and suppliers.
Gurpreet Singh, ELLKAY Vice President of Interoperability Solutions, said, âWe have loved working with the OncoSpark team to ensure oncology patients have clear coverage of their care. Our interoperability experts are happy to manage back-end connectivity for our partners so that they can focus their resources on their core business. OncoSpark’s passion for ensuring a seamless workflow for its oncology partners drove the ELLKAY team to ensure that we have tailored interoperability connectivity to do their part.
Johnson added, âELLKAY’s commitment to effective interoperability and an unparalleled understanding of all aspects of healthcare barriers, opportunities and proven outcomes have made it the go-to partner in healthcare. ‘OncoSpark and its mission. We already have an interest and are working with ELLKAY to expand beyond the oncology department. line.”
OncoSpark is a team of over 400 members committed to delivering value-driven, technology-driven service-driven care through data. OncoSpark’s combination of clinical, administrative and industrial expertise has made OncoSpark one of the most trusted and innovative partners in oncology for practices, payers, providers and providers who seek an approach and a more efficient strategy for current inefficient operational and financial processes. The depth of technology and subject matter expertise have made Oncospark the trusted partner for over 150 people in the healthcare industry. Contact OncoSpark directly at [email protected] to learn more about our risky strategies, data, solutions and platforms.
ELLKAY is a recognized leader in healthcare connectivity, providing solutions and services nationwide. With 19 years of industry experience, ELLKAY empowers hospitals and healthcare systems, diagnostic laboratories, healthcare IT providers, payers and other healthcare organizations to have technology and cutting-edge solutions. With over 58,000 connected cabinets, ELLKAY’s arsenal of system capabilities has grown to over 750 EMR / PMS systems in over 1,100 versions. To learn more about the ELLKAY Interoperability Platform or to discuss how this solution can help your organization, visit ELLKAY.com, call 201-791-0606 or email TeamELLKAY @ ELLKAY. com.
View original content to download multimedia: https://www.prnewswire.com/news-releases/oncospark-and-ellkay-announce-new-partnership-to-use-interoperability-to-solve-prior-authorization-challenges -in-oncology-301394265.html